Urwashanza/europrocure-10-public-procurement huggingface dataset:
Public procurement notice: Contract Notice
Published: 2020-04-29
Buyer: Procurement Assist Ltd c/o Integrated Facilities Management Bolton Ltd (iFM Bolton)
Country: UK
Contract type: Works
Procedure: Restricted procedure
CPV classification: 45210000: Building construction work
Estimated value: 75000000 GBP
Submission deadline: 2020-05-24
Award criteria: The most economic tender

Technical requirements: Procurement Assist Ltd is seeking service providers to take part in tendering for a place on a 60 month Dynamic Purchasing System for bathroom supply and installations.
The DPS will be available for use by iFM Bolton and the whole public sector from across the United Kingdom. The DPS initial application period is 30 days but will remain open until 31 May 2025. Applications from service providers can be made at any time during this period.
The DPS is intended to be a fast route to market for clients, with clients not needing any further engagement with OJEU procurement processes.
The contracting authority considers that this contract may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement.
For more information about this opportunity, please visit the Delta eSourcing portal at: https://www.delta-esourcing.com/tenders/UK-UK-Bolton:-Building-construction-work./V533W2J364
To respond to this opportunity, please click here: https://www.delta-esourcing.com/respond/V533W2J364


Award value: 75000000
Public procurement notice: Contract Notice
Published: 2020-04-29
Buyer: Apex Housing Association
Country: UK
Contract type: Works
Procedure: Open procedure
CPV classification: 45211000: Construction work for multi-dwelling buildings | 45211100
Estimated value: 15000000 GBP
Submission deadline: 2020-05-29
Award criteria: The most economic tender

Technical requirements: The project is for the provision and the delivery of multiple social housing units in the area of Ligoniel, Beifast, as defined in the MOI by means of design and build. Participants must provide the land, design, construction and ensure completion of the scheme for Apex in accordance with the DfC Housing Association Guide; client's requirements and statutory body requirements.
(ii) have an exclusive arrangement with the landowner enabling the transfer of the site to Apex, with clear non-encumbered title, to submit proposals for the provision of social housing on the site.
The project is for the provision of the delivery of multiple social housing units in areas of acute housing need within the Ligoniel Development Area, by means of design and build. Developers must provide the land, design and construction and ensure completion of the scheme for Apex in accordance with the DfC Housing Association Guide; client's requirements and statutory body requirements.
(ii) have an exclusive arrangement with the site owner enabling the transfer of the site to Apex with clear non–encumbered title, to submit proposals for the provision of social housing on the site.
Apex anticipates that the minimum size of development which it will consider as part of the evaluation is five units, however, it reserves, at its sole discretion, the right to contract with a developer in respect of a site with fewer units.


Award value: 15000000
Public procurement notice: Additional Information
Published: 2020-04-29
Buyer: Newforge Community Development Trust
Country: UK
Contract type: Works
Procedure: Restricted procedure
CPV classification: 45210000: Building construction work | 45211350 | 45212000: Construction work for leisure buildings | 45212220 | 45213100
Submission deadline: 2020-05-05
Award criteria: The most economic tender

Technical requirements: Whilst the project is a standalone project with clear access to the site, it will be constructed within the existing Newforge Country Club site which will remain live throughout the project duration.
Public procurement notice: Prior Information Notice Without Call For Competition
Published: 2020-04-29
Buyer: Leidos Supply
Country: UK
Contract type: Supplies
CPV classification: 33185000 | 33185100 | 35000000: Security, fire-fighting, police and defence equipment | 35113000: Safety equipment | 35810000: Individual equipment
Estimated value: 1000000 GBP

Technical requirements: Team Leidos would like to make interested suppliers aware that it intends to tender for the supply of aural protection for musicians which includes active aural protection suitable for use by musicians.
This will involve procurement of active aural protection suitable for use by musicians.The hearing protection should be discrete in order to maintain appropriate appearance of ceremonial dress. They should provide impulse noise protection and must be suitable for outdoor use. Automatic protection should activate when hearing is at risk. This would require an adaptive system which reacts to dangerous noise levels.
The tender process is likely to include user trials, for which bidders will need to provide sample equipment.
Interested parties should contact Anthony Cover (Anthony.Cover100@mod.gov.uk) to register their interest.
Leidos Supply Ltd is a wholly owned subsidiary of Leidos Europe Ltd, is undertaking this procurement as body governed by public law and as subcontractor to Leidos Europe Ltd to meet a requirement of the UK Ministry of Defence pursuant to the Logistics Commodities and Services Transformation Delivery Partner Contract (LCS(T)/0001 dated 16 April 2015) between Leidos Europe Limited and the UK.


Award value: 1000000
Public procurement notice: Contract Notice
Published: 2020-04-29
Buyer: Enabel
Country: RW
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33000000
Submission deadline: 2020-05-29
Award criteria: The most economic tender

Technical requirements: Lääketieteelliset laitteet, farmaseuttiset valmisteet ja henkilökohtaiseen hygieniaan liittyvät tuotteet
Fourniture d’un panel de quatre tests rapides de laboratoire destinés aux soins prénatals pour les projets Enabel au Rwanda
Fourniture d’un panel de quatre tests rapides de laboratoire destinés aux soins prénatals pour les projets Enabel au Rwanda.
Levering van een panel van vier snelle laboratoriumtests voor prenatale zorg voor Enabel-projecten in Rwanda
Levering van een panel van vier snelle laboratoriumtests voor prenatale zorg voor Enabel-projecten in Rwanda.
Public procurement notice: Contract Notice
Published: 2020-04-29
Buyer: Enabel RDC
Country: CD
Contract type: Supplies
Procedure: Open procedure
CPV classification: 09332000: Solar installation
Estimated value: 220000 EUR
Submission deadline: 2020-06-01
Award criteria: Lowest price

Technical requirements: Marché de fournitures relatif a la fourniture, installation et mise en service des sytemes photovoltaïques de production d’électricite dans deux centres d’application (Mazzarello et Don Bosco) à Mbuji-Mayi et dans la centrale de distribution régionale (Camene) à Gemena
Marché de fournitures relatif a la fourniture, installation et mise en service des sytemes photovoltaïques de production d’électricite dans deux centres d’application (Mazzarello et Don Bosco) à Mbuji-Mayi et dans la centrale de distribution régionale (Camene) à Gemena.
Opdracht van levering, plaatsing en indienststelling van photovoltaïsche systemen voor de elektriciteitsproductie in twee opleidingscentra (Mazzarello et Don Bosco) te Mbuji-Mayi en in het regionale distributiecentrum (Camene) te Gemena
Opdracht van levering, plaatsing en indienststelling van photovoltaïsche systemen voor de elektriciteitsproductie in twee opleidingscentra (Mazzarello et Don Bosco) te Mbuji-Mayi en in het regionale distributiecentrum (Camene) te Gemena.


Eligibility requirements: Voir CSC RDC1217211-26/RDC 1419311-04 sur https://www.enabel.be/fr/content/marches-publics
Zie CSC RDC1217211-26/RDC1419311-04 op https://www.enabel.be/fr/content/marches-publics

Award value: 220000
Public procurement notice: Contract Award Notice
Published: 2020-04-29
Buyer: Ministry of Defence, ISTAR, Special Projects Communication and Force Protection (SPCFP)
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 35125000: Surveillance system
Estimated value: 4600000 GBP
Award criteria: Lowest price

Technical requirements: The contract is for the support of the Ground Based ISTAR system. The Ground Based ISTAR systems are a technically complex, multi-sensor surveillance platform utilised by the British Armed Forces. The contract will support, repair, maintain and store the specified Ground Based ISTAR system.
This contract is put in place to continue the support of the Ground Based ISTAR system, when the current support contract ends.
The contract is for the support of the Ground Based ISTAR system. The Ground Based ISTAR systems are technically complex, multi-sensor surveillance platform used by the British Armed Forces. The contract will support, repair, maintain and store the specified Ground Based ISTAR system.
The contract is put in place to continue the support of the Ground Based ISTAR system, when the current support contract has ends.
General Dynamics UK Ltd is the current support contractor and holds over 10 years of experience in supporting the Ground Based ISTAR system across various engineering activities. It holds key equipment support information on the Ground Based ISTAR system, to which no other contractor would have access and are the only economic operator with access to the knowledge, skills and experience required to understand the many specific and complex configurations and integration aspects of the whole platform. No other contractor could therefore support, maintain, repair and dispose of the specified Ground Based ISTAR system in its entirety to the standard required to ensure the safe functioning of the Armed Forces.
The authority reserves the right to amend any condition related to security of information to reflect any changes in national law or government policy. If any contract documents are accompanied by instructions on safeguarding classified information (e.g. a Security Aspects Letter), the authority reserves the right to amend the terms of these instructions to reflect any changes in national law or government policy, whether in respect of the applicable protective marking scheme, specific protective markings given, the aspects to which any protective marking applies or otherwise. The link below to the Gov.uk website provides information on the Government Security Classification.
Advertising Regime OJEU: this contract opportunity is published in the Official Journal of the European Union (OJEU), the MoD Defence Contracts Bulletin and www.contracts.mod.uk


Winner: GD Mission Systems UK
Award value: 4600000
Number of bids: 1
Public procurement notice: Contract Award Notice
Published: 2020-04-29
Buyer: The Secretary of State for Health and Social Care acting as part of the Crown through the Department of Health and Social Care
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 541200 GBP
Award criteria: Lowest price

Technical requirements: A requirement to secure lopinavir/ritonavir tablets for trials for treatments for Covid-19. Urgent delivery required of available stocks.
A situation of extreme urgency exists both in the UK and across the World, in the context of the spread of Covid-19. Lopinavir/ritonavir tablets, one of the drugs of choice worldwide for the treatment of Covid-19 is scarce in supply and the contracting authority having identified a supplier that was ready willing and able to supply lopinavir/ritonavir tablets needed to move quickly to secure this supply. Failure to do this would have resulted in the lopinavir/ritonavir tablets being sold by the supplier to another country due to the high demand globally. As such and at this time, the timelines for the open procedure, restricted procedure (even where accelerated) and the competitive procedure with negotiation could not be complied with in order for DHSC is to secure this supply of lopinavir/ritonavir tablets.
The contracts is for the benefit of the authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies and the local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health-related services in the United Kingdom, Crown Dependencies and British Overseas territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.
This contract was awarded pursuant to a procurement exercise carried out by the contracting authority to identify suppliers able to urgently supply readily available stocks of antimalarial and anti-retroviral medicinal products for the treatment of Covid-19. This procurement exercise was commenced by the contracting authority on 26 February 2020 and an invitation to negotiate and submit an offer was issued to suppliers in this regard on 2 March 2020.


Winner: Mylan UK Healthcare Ltd
Award value: 541200
Number of bids: 1
Public procurement notice: Contract Award Notice
Published: 2020-04-29
Buyer: The Secretary of State for Health and Social Care acting as part of the Crown through the Department of Health and Social Care
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 398919.6 GBP
Award criteria: Lowest price

Technical requirements: A requirement to secure chloroquine tablets for trials for treatments for Covid-19. Urgent delivery required of available stocks.
A situation of extreme urgency exists both in the UK and across the World, in the context of the spread of Covid-19. Chloroquine tablets, one of the drugs of choice worldwide for the treatment of Covid-19 is scarce in supply and the Contracting Authority having identified a supplier that was ready willing and able to supply chloroquine tablets needed to move quickly to secure this supply. Failure to do this would have resulted in the chloroquine tablets being sold by the supplier to another country due to the high demand globally. As such and at this time, the timelines for the open procedure, restricted procedure (even where accelerated) and the competitive procedure with negotiation could not be complied with in order for DHSC is to secure this supply of chloroquine tablets.
The contracts is for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies and the local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health-related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.
This contract was awarded pursuant to a procurement exercise carried out by the contracting authority to identify suppliers able to urgently supply readily available stocks of antimalarial and anti-retroviral medicinal products for the treatment of Covid-19. This procurement exercise was commenced by the contracting authority on 26 February 2020 and an invitation to negotiate and submit an offer was issued to suppliers in this regard on 2 March 2020.


Winner: Alliance Pharmaceuticals Ltd
Award value: 398919.6
Number of bids: 1
Public procurement notice: Contract Award Notice
Published: 2020-04-29
Buyer: The Secretary of State for Health and Social Care acting as part of the Crown through the Department of Health and Social Care
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 32857.55 GBP
Award criteria: Lowest price

Technical requirements: A requirement to secure lopinavir/ritonavir tablets for trials for treatments for Covid-19. Urgent delivery required of available stocks.
A situation of extreme urgency exists both in the UK and across the World, in the context of the spread of Covid-19. Lopinavir/ritonavir tablets, one of the drugs of choice worldwide for the treatment of Covid-19 is scarce in supply and the contracting authority having identified a supplier that was ready willing and able to supply lopinavir/ritonavir tablets needed to move quickly to secure this supply. Failure to do this would have resulted in the lopinavir/ritonavir tablets being sold by the supplier to another country due to the high demand globally. As such and at this time, the timelines for the open procedure, restricted procedure (even where accelerated) and the competitive procedure with negotiation could not be complied with in order for DHSC is to secure this supply of lopinavir/ritonavir tablets.
The contracts is for the benefit of the authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies and the local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health-related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.
This contract was awarded pursuant to a procurement exercise carried out by the contracting authority to identify suppliers able to urgently supply readily available stocks of antimalarial and anti-retroviral medicinal products for the treatment of Covid-19. This procurement exercise was commenced by the contracting authority on 26 February 2020 and an invitation to negotiate and submit an offer was issued to suppliers in this regard on 2 March 2020.


Winner: AbbVie Ltd
Award value: 32857.55
Number of bids: 1
Public procurement notice: Contract Award Notice
Published: 2020-04-29
Buyer: The Secretary of State for Health and Social Care acting as part of the Crown through the Department of Health and Social Care
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 17388.4 GBP
Award criteria: Lowest price

Technical requirements: A requirement to secure hydroxychloroquine tablets for trials for treatments for Covid-19. Urgent delivery required of available stocks.
A situation of extreme urgency exists both in the UK and across the world, in the context of the spread of Covid-19. Hydroxychloroquine tablets, one of the drugs of choice worldwide for the treatment of Covid-19 is scarce in supply and the contracting authority having identified a supplier that was ready willing and able to supply hydroxychloroquine tablets needed to move quickly to secure this supply. Failure to do this would have resulted in the hydroxychloroquine tablets being sold by the supplier to another country due to the high demand globally. As such and at this time, the timelines for the open procedure, restricted procedure (even where accelerated) and the competitive procedure with negotiation could not be complied with in order for DHSC is to secure this supply of hydroxychloroquine tablets.
The contracts is for the benefit of the authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies and the local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health-related services in the United Kingdom, Crown Dependencies and British overseas territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly and Scottish Ministers.
This contract was awarded pursuant to a procurement exercise carried out by the contracting authority to identify suppliers able to urgently supply readily available stocks of antimalarial and anti-retroviral medicinal products for the treatment of Covid-19. This procurement exercise was commenced by the contracting authority on 26 February 2020 and an invitation to negotiate and submit an offer was issued to suppliers in this regard on 11 March 2020.


Winner: Mawdsley Brooks and Co. Ltd
Award value: 17388.4
Number of bids: 1
Public procurement notice: Contract Award Notice
Published: 2020-04-29
Buyer: The Secretary of State for Health and Social Care acting as part of the Crown through the Department of Health and Social Care
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 267900 GBP
Award criteria: Lowest price

Technical requirements: A requirement to secure chloroquine phosphate 80 mg/5 ml oral solution for trials for treatments for Covid-19. Urgent delivery required of available stocks.
A situation of extreme urgency exists both in the UK and across the world, in the context of the spread of Covid-19. Chloroquine phosphate 80 mg/5 ml oral solution, one of the drugs of choice worldwide for the treatment of Covid-19 is scarce in supply and the contracting authority having identified a supplier that was ready willing and able to supply chloroquine phosphate 80 mg/5 ml oral solution needed to move quickly to secure this supply. Failure to do this would have resulted in the chloroquine phosphate 80 mg/5 ml oral solution being sold by the supplier to another country due to the high demand globally. As such and at this time, the timelines for the open procedure, restricted procedure (even where accelerated) and the competitive procedure with negotiation could not be complied with in order for DHSC is to secure this supply of chloroquine phosphate 80 mg/5 ml oral solution.
The contracts is for the benefit of the authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies and the local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health-related services in the United Kingdom, Crown Dependencies and British overseas territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly and Scottish Ministers.
This contract was awarded pursuant to a procurement exercise carried out by the contracting authority to identify suppliers able to urgently supply readily available stocks of antimalarial and anti-retroviral medicinal products for the treatment of Covid-19. This procurement exercise was commenced by the contracting authority on 26 February 2020 and an invitation to negotiate and submit an offer was issued to suppliers in this regard on 2 March 2020.


Winner: Wallace Manufacturing Chemists Ltd
Award value: 267900
Number of bids: 1